Impact of Adipose Tissue Repartition on the Time Course of Vascular Dysfunction - the NUMEVOX Cohort
NCT ID: NCT00997165
Last Updated: 2009-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2008-03-31
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Weight Loss on Body Composition and Metabolic Function in Women With Lipedema
NCT03271034
Adipocyte, Insulin-resistance and Immunity : Evaluation of Interleukin-7 in Lipodystrophy, Diabetes and Obesity
NCT01784289
CT Evaluation of Cardiovascular Risk Markers in Obese Patients
NCT03111693
Obesity-hypoventilation in Metabolic Syndrom Patients
NCT04839419
Non Alcoholic Fatty Liver Disease and Coronary Heart Disease in Type 2 Diabetes Patients
NCT04462081
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Metabolic syndrome (MS)
Patients suspected of metabolic syndrome without sleep apnea or liver steatosis
No interventions assigned to this group
MS with sleep apnea
Metabolic syndrome with sleep apnea
No interventions assigned to this group
MS with Liver steatosis
Metabolic syndrome with liver steatosis
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \> 18 years old
* suspected of metabolic syndrome
* affiliated to french social health care
Exclusion Criteria
* pregnancy
* no informed consent
* not eligible for the study (no MS, cancer)
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Angers
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
UH Angers
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
pierre henri Ducluzeau, MD PhD
Role: STUDY_DIRECTOR
UH Angers
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pôle Maladies Métaboliques et Médecine Interne
Angers, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHU-Promoteur 08-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.